Could haemophilia be 'cured' by a new gene therapy that costs £2.5million per jab?

In trials, a single jab of Roctavian left nine in ten patients symptom-free and no longer in need of the daily injections usually required to control their condition.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news